|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 9/08 | (2013.01) | ||
| A61K 38/12 | (2006.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61K 38/12 | (2013.01) |
| (11) | Patento numeris | 3528786 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17794677.9 |
| Europos patento paraiškos padavimo data | 2017-10-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/076519 |
| Data | 2017-10-17 |
| (87) | Numeris | WO 2018/073269 |
| Data | 2018-04-26 |
| (30) | Numeris | Data | Šalis |
| 201662411024 P | 2016-10-21 | US |
| (72) |
GJONI, Tina , HR
STRAZIC, Dubravka , HR
|
| (73) |
Xellia Pharmaceuticals ApS ,
Dalslandsgade 11, 2300 Copenhagen S,
DK
|
| (54) | LIQUID FORMULATIONS OF DAPTOMYCIN |
| LIQUID FORMULATIONS OF DAPTOMYCIN |